{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:53:17Z","timestamp":1790031197963,"version":"4.0.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009060","name":"SIDACTION","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institut National de la Sante et de la Recherche Medicale"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/jac\/dky316","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T12:49:23Z","timestamp":1531572563000},"page":"3129-3136","source":"Crossref","is-referenced-by-count":17,"title":["Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads"],"prefix":"10.1093","volume":"73","author":[{"given":"Narjis","family":"Boukli","sequence":"first","affiliation":[{"name":"AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Boyd","sequence":"additional","affiliation":[{"name":"INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Collot","sequence":"additional","affiliation":[{"name":"AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Meynard","sequence":"additional","affiliation":[{"name":"AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Service de Maladies Infectieuses, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Girard","sequence":"additional","affiliation":[{"name":"AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Service de Maladies Infectieuses, Paris, France"},{"name":"Sorbonne Universit\u00e9s, UPMC Universit\u00e9 Paris 06, INSERM, Institut Pierre Louis d\u2019\u00e9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP UMRS 1136), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Morand-Joubert","sequence":"additional","affiliation":[{"name":"AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France"},{"name":"Sorbonne Universit\u00e9s, UPMC Universit\u00e9 Paris 06, INSERM, Institut Pierre Louis d\u2019\u00e9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP UMRS 1136), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"key":"key\n\t\t\t\t20181023055512512_dky316-B1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/cid\/ciu834","article-title":"Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access","volume":"60","author":"Delaugerre","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40265-015-0515-6","article-title":"Modifying antiretroviral therapy in virologically suppressed HIV-1-infected patients","volume":"76","author":"Collins","year":"2016","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B4"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B5","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/jac\/dkx042","article-title":"Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies\/mL: a 2014 French nationwide study","volume":"72","author":"Assoumou","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1468-1293.2012.01002.x","article-title":"Comparison of resistance mutation patterns in historical plasma HIV RNA genotypes with those in current proviral HIV DNA genotypes among extensively treated patients with suppressed replication","volume":"13","author":"Delaugerre","year":"2012","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jac\/dkq544","article-title":"Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia","volume":"66","author":"Wirden","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B8","doi-asserted-by":"crossref","first-page":"e0117430.","DOI":"10.1371\/journal.pone.0117430","article-title":"HIV drug resistance mutations in proviral DNA from a community treatment program","volume":"10","author":"Derache","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B9","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/jac\/dkw146","article-title":"Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine\/emtricitabine\/tenofovir disoproxil fumarate combination","volume":"71","author":"Lambert-Niclot","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jmv.21390","article-title":"LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01)","volume":"81","author":"Avettand-F\u00e8no\u00ebl","year":"2009","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B11","author":"ANRS AC-11 Resistance Study Group","year":"2014"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B12","author":"Conseil national du sida et des h\u00e9patites virales"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jviromet.2017.10.016","article-title":"Interest of proviral HIV-1 DNA genotypic resistance testing in virologically suppressed patients candidate for maintenance therapy","volume":"251","author":"Allavena","year":"2018","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3851\/IMP1753","article-title":"Predicting antiretroviral drug resistance from the latest or the cumulative genotype","volume":"16","author":"Garcia","year":"2011","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP2010","article-title":"Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients","volume":"17","author":"Barth","year":"2012","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B16","doi-asserted-by":"crossref","first-page":"e1003203.","DOI":"10.1371\/journal.pcbi.1003203","article-title":"The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients","volume":"9","author":"Beerenwinkel","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.meegid.2016.08.031","article-title":"HIV-1 drug resistance and resistance testing","volume":"46","author":"Clutter","year":"2016","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1468-1293.2009.00814.x","article-title":"HIV-1 proviral resistance mutations: usefulness in clinical practice","volume":"11","author":"Kabamba-Mukadi","year":"2010","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B19","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/jac\/dkx233","article-title":"HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir\u2009+\u2009lamivudine in the maintenance DOLULAM pilot study","volume":"72","author":"Charpentier","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.43.1.406-413.2005","article-title":"Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis","volume":"43","author":"Palmer","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B21","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/QAD.0000000000000267","article-title":"Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure","volume":"28","author":"Mohamed","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B22","doi-asserted-by":"crossref","first-page":"e86771.","DOI":"10.1371\/journal.pone.0086771","article-title":"Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure","volume":"9","author":"Vandenhende","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jac\/dkv395","article-title":"Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression","volume":"71","author":"Gantner","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B24","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/jmv.24581","article-title":"HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy","volume":"88","author":"Michelini","year":"2016","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B25","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/jac\/dky130","article-title":"Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART","volume":"73","author":"Nouchi","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B26","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1128\/JVI.79.3.1975-1980.2005","article-title":"G\u2192A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo","volume":"79","author":"Kieffer","year":"2005","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B27","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.1128\/JVI.01223-10","article-title":"Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure","volume":"84","author":"Kim","year":"2010","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20181023055512512_dky316-B28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcv.2016.07.007","article-title":"Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA","volume":"82","author":"Zaccarelli","year":"2016","journal-title":"J Clin Virol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/11\/3129\/26144728\/dky316.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T07:26:46Z","timestamp":1720423606000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/11\/3129\/5075858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,17]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,8,17]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky316","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,8,17]]}}}